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The DNA sensor, cyclic GMP-AMP synthase (cGAS), is essential for the detection of viral infection. In a recent
issue of Science, two studies, Bridgeman et al. (2015) and Gentili et al. (2015), report a novel mechanism for
propagating an antiviral signal between cells, based on the transfer of the cGAS enzymatic product, cyclic
GMP-AMP (cGAMP), in viral particles.An organism’s innate immune response to
pathogens is controlled by a remarkable
diversity of cell types operating from
distinct locations. To coordinate this
complex reaction in a timely manner,
and to quickly adapt to the stage of the
infection process, individual cells need
to communicate with other cells. Commu-
nication within the innate immune system
mainly involves cytokines and chemo-
kines, which are produced by pathogen-
infected cells and are recognized by cell
surface receptors. The cytokine family of
the type I interferons (IFNs) are central to
coordinate protection against viral in-
fection (Ivashkiv and Donlin, 2014). Once
released by virus-infected cells, type I
IFNs rapidly disseminate and induce an
antiviral state in acceptor cells. As such,
the type I IFN-mediated priming of non-in-
fected cells is a highly efficient way to
interfere with further viral spread and is
key to successful elimination of the virus.
The induction of type I IFNs in virus-in-
fected cells is driven by the activation
of intracellular pattern recognition re-
ceptors, which are specialized for the
detection of virus-derived nucleic acids
(Wu and Chen, 2014). Whereas RNA heli-
cases sense RNA viruses, the nucleotidyl-
transferase cyclic GMP-AMP synthase
(cGAS) has recently been identified as
a crucial innate sensor for DNA viruses
and retroviruses (Sun et al., 2013; Gao
et al., 2013). Upon binding cytosolic
DNA, cGAS produces the second
messenger cyclic GMP-AMP (cGAMP),
which subsequently activates the adaptor
protein, stimulator of interferon genes
(STING). Activation of STING in turn in-
duces de novo gene expression leading
to the upregulation of interferon-stimu-
lated genes (ISGs) and release of type I
IFNs and proinflammatory cytokines.
However, in addition to this traditionalroute to propagate an antiviral state, two
recent studies show how the cGAS-
STING-axis also uses an alternate mech-
anism to allow intercellular communica-
tion. Bridgeman et al. (2015) and Gentili
et al. (2015) describe a novel mechanism
by which cells signal the presence of an
ongoing viral infection. They report that
cGAS-dependent recognition of DNA
virus or retrovirus infection leads to the
encapsulation of cGAMP into progeny
virus particles. Following infection of
subsequent target cells, virus-transferred
cGAMP then stimulates an antiviral state
in a STING-dependent manner (Figure 1).
The study by Gentili et al. (2015) began
with an unexpected finding: in an attempt
to transduce human monocyte-derived
dendritic cells (DCs) with a cGAS-ex-
pressing lentivirus, the authors observed
strong activation of DCs as measured
by upregulation of CD86 expression,
whereas a control virus vector was not
active. Puzzling, however, was that the
stimulatory property of the cGAS-encod-
ing lentivirus did not correlate with the
transduction efficiency, since activation
was also apparent in cells that were barely
transduced. This led the authors to hy-
pothesize that, instead of the expression
of cGAS in infected cells, some other
stimulatory signal, which is transferred
by the lentivirus vector, is responsible for
activation in the target cells. They tested
this by challenging DCs with virus-like
particles (VLPs) that were produced in
the presence of cGAS but that did not
themselves encode for cGAS. Indeed
VLPs from cGAS-expressing cells eli-
cited strong activation of DCs. Similarly,
Bridgeman et al. (2015) found that incuba-
tion of macrophages or fibroblasts with
lentiviral particles collected from cells
overexpressing cGAS lead to the upregu-
lation of type I IFNs and ISGs. Importantly,Cell Host & Microbe 18, Sthe induced IFN response was also func-
tionally relevant, since it protected cells
against a subsequent challenge with
ECMV or HSV-1.
But what are the players involved in the
transmission of the antiviral signal? Previ-
ous reports had demonstrated that cell-
derived antiviral proteins can be pack-
aged into lentivirus particles and can
thereby be delivered into non-infected
cells (Mariani et al., 2003). Somehow
akin to this, Bridgeman et al. (2015) postu-
lated that such a scenario would also
occur for the host-derived antiviral mole-
cule cGAMP.
The first step toward proving this idea
was to confirm the production and trans-
mission of cGAMP. Indeed, both groups
observed that the replacement of wild-
type cGAS in producer cells with a cata-
lytically inactive mutant that is unable
to synthesize cGAMP resulted in loss of
the stimulatory capacity of the viruses
produced in those cells. Another piece
of evidence for a role of cGAMP came
from experiments with STING-deficient
cells. Both groups found that recipient
cells lacking STING were completely un-
responsive toward virus stocks collected
from cGAS-expressing cells. Finally,
both studies demonstrated, by using
mass spectrometry, that cGAMP is pre-
sent in extracts from viruses produced in
cGAS-expressing cells. As such, it was
concluded that cGAMP was the missing
link that connected cGAS enzymatic ac-
tivity in producer cells with the antiviral im-
mune response of recipient cells.
Supernatants of infected cells contain
multiple additional vesicles, such as exo-
somes or apoptotic bodies, which could,
in principle, also account for the transmis-
sion of cGAMP and thus be responsible
for the stimulatory effect. To formally
prove the role of viral particles in cGAMPeptember 9, 2015 ª2015 Elsevier Inc. 263
Figure 1. Transfer of cGAMP by Viral Particles
Upon infection, DNA viruses and retroviruses activate cGAS, which leads to the production of cGAMP. In the virus-infected cells, endogenous cGAMP then ac-
tivates STING, which triggers downstream signaling to induce type I IFN and ISG expression. Next to the cell-intrinsic activation of STING, cGAMP can also be
encapsulated into progeny virus or virus-like particles. Subsequent infection of new target cells releases cGAMP, which upregulates type I IFNs and ISGs in a
STING-dependent manner.
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Gentili et al. (2015) employed a series of
elegant experiments. First, crude virus
preparations were subjected to differential
centrifugation to separate distinct cell-
derived vesicles from one another. Com-
parison of the different fractions revealed
that the major activity corresponded to
those that contained the virus proteins
Gag or p24. Second, ‘‘mock’’ virus pre-
pared in the absence of either the viral
proteins Gag/Pol or the fusogenic viral
envelope protein VSV-G lacked the IFN-
inducing property. Third, blocking exo-
somes or apoptotic bodies in producer
cells did not affect the IFN response of
the recipient cells (Bridgeman et al.,
2015), but inhibition of virion release by
overexpression of tetherin in producer
cells (Bridgeman et al., 2015; Gentili
et al., 2015) or blocking HIV-1 (Gentili
et al., 2015) entry in target cells disrupted
IFN induction in the recipient cells.
Notably, the packaging and transfer of
cGAMPwasnot restricted to VSV-Gpseu-
dotyped virus preparations, but the effect
was also evident with other envelope pro-
teins such as the influenza proteins H1N1
and H5N1 (Gentili et al., 2015), thogotovi-
rus glycoprotein (Bridgeman et al., 2015),
or by using MLV (Gentili et al., 2015).
Moreover, both groups found that fully in-
fectious HIV-1 contains cGAMP, in cases
in which the virus was produced in the
presence of exogenous cGAS. Together,264 Cell Host & Microbe 18, September 9, 20this confirmed that the production of fuso-
genic viral particles is indeed needed for
the transactivation of recipient cells.
The question then arose whether, dur-
ing virus infection, ‘‘naturally’’ produced
cGAMP would also be incorporated into
progeny virus and contribute to the anti-
viral response of newly infected cells. To
explore this, the investigators turned to
distinct DNA viruses (MCMV [Bridgeman
et al., 2015; Gentili et al., 2015] and MVA
[Gentili et al., 2015]), which are known to
activate cGAS and STING. In both
studies, virus extracts from infected
cGAS-competent cells contained cGAMP
when analyzed by mass spectrometry.
Consistent with this, Bridgeman et al.
(2015) found that MCMV, which was
propagated in cGAS-competent cells,
was able to upregulate type I IFN expres-
sion in a cGAS-independent, but STING-
dependent, manner.
Since their initial discovery, type I IFNs
have dominated our view of how cells
propagate an antiviral state to non-in-
fected cells and there is no doubt that
these (and other) cytokines play the major
role in antiviral defense. Still, insight
into the molecular basis of innate im-
mune recognition in general, and the
illumination of the cGAS-STING pathway
in particular, have uncovered novel mech-
anisms of cytokine-independent cellular
communication. Recently, we have
shown that cGAMP can be transferred15 ª2015 Elsevier Inc.through gap junctions (Ablasser et al.,
2013). The discovery of cGAMP transmis-
sion by viral particles now reveals an addi-
tional exciting mechanism of intercellular
communication within the innate immune
system, raising new questions and sug-
gesting new applications at the same
time.
As such, it is intriguing to speculate
whether the packaging of cGAMP into
progeny virus is random and variable or
whether it reflects a specific antiviral pro-
cess that might have functional conse-
quences for the virus. If the latter holds
true, it would be interesting to explore
whether viruses have evolved strategies
to block this event, as yet another way
to evade or down-modulate the innate
response. This new way might also be
relevant for other pathogens that replicate
in the host cytosol and trigger cGAS, and
it would be worthwhile to explore this
further. As the authors point out, one
reason why this mechanism has gone un-
noticed thus far might be that the cells
typically used for virus preparation usually
lack cGAS. As such, might the switch to
cGAS-competent producer cells atten-
uate such virus preparations? Another
consideration stemming from these
studies is the potential application of vi-
rus-encapsulated cGAMP for the devel-
opment of novel vaccine approaches.
Indeed, based on its strong immunosti-
mulatory property, cGAMP holds great
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several immunotherapeutic applications.
The use of lentiviral particles as carriers
for the in vivo delivery of cGAMP might
be an advantage in this setting.REFERENCES
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Intracellular nucleotide-binding leucine-rich repeat (NLR) receptors play central roles in human and plant
innate immunity. In this issue of Cell Host & Microbe, Wang et al. (2015) show that a single plant NLR can
detect diverse pathogen effectors by partneringwith different scaffolding proteins, which can each recognize
distinct effector targets.To detect the presence of pathogens, the
innate immune systems of plants and an-
imals both rely on a combination of cell
surface receptors and intracellular recep-
tors. Although their immune systems are
thought to have evolved independently,
the intracellular receptors of plants and
mammals share similar structural do-
mains in that most all of them contain a
nucleotide-binding domain and leucine-
rich repeats (NLR). In plants, NLR recep-
tors are noted for their specificity, with
most NLRs appearing to detect only a sin-
gle pathogen protein. How this specificity
is achieved at amolecular level has been a
topic of intense study since the first plant
NLR was described in 1994 (Whitham
et al., 1994). Research in the ensuing
two decades has revealed that different
NLR proteins have evolved different
recognition mechanisms, with some
NLRs detecting pathogen proteins via
direct binding, while others detect patho-
gens indirectly by detecting modifications
to other host proteins induced by the
pathogen (DeYoung and Innes, 2006).The indirect recognition mechanism
most typically involves formation of a
pre-activation complex between an NLR
protein and a second host protein that is
directly targeted by a pathogen effector
(DeYoung and Innes, 2006). Modification
of the effector target is then thought to
trigger a conformational change in the
NLR protein that enables nucleotide ex-
change and adoption of an activated
state (Takken and Goverse, 2012). This
type of indirect recognition mechanism
offers several advantages over a direct
recognition mechanism from the plant’s
perspective. First, to escape detection,
the pathogen would have to eliminate
the activity of the detected effector, which
presumably would decrease its virulence.
With a direct recognition mechanism, in
contrast, detection can potentially be
evaded by simply mutating a surface
residue involved in NLR binding, which
would likely not affect effector function.
A second advantage of the indirect re-
cognition system is that it enables detec-
tion of multiple different effectors ifthey cause similar modifications to the
same effector target. As an example, the
Arabidopsis RPM1 NLR protein detects
modification of RPM1 INTERACTING
PROTEIN 4 (RIN4) induced by two
sequence unrelated effector proteins,
AvrB and AvrRpm1 (Liu et al., 2011). This
ability to detectmultiple different effectors
with a single NLR is likely critical given
that plants lack an adaptive immune sys-
tem. With such a system, a single NLR
can mediate recognition of not only
diverse effectors, but also effectors from
diverse pathogens.
In this issue, Wang et al. (2015) take
the concept of indirect recognition a
step further. They show that the ZAR1
NLR protein of Arabidopsis can detect
different bacterial effector proteins via a
combinatorial system that enables ZAR1
to indirectly associate with different
effector targets (Figure 1). ZAR1 was orig-
inally identified as an NLR protein
required for recognition of the effector
protein HopZ1a fromPseudomonas syrin-
gae (Lewis et al., 2010). HopZ1a belongseptember 9, 2015 ª2015 Elsevier Inc. 265
